Overview
ICD-10 code C83.58 is a specific code used to classify a type of non-Hodgkin lymphoma known as diffuse large B-cell lymphoma.
This code falls under the larger category of malignant immunoproliferative diseases and is essential for accurate medical billing and record-keeping.
Signs and Symptoms
Patients with diffuse large B-cell lymphoma may experience symptoms such as swelling of lymph nodes, fever, night sweats, weight loss, and fatigue.
Symptoms can vary from person to person and may be mistaken for other conditions, which makes a proper diagnosis crucial.
Causes
The exact cause of diffuse large B-cell lymphoma is unknown, but it is believed to be linked to genetic mutations and abnormalities in the immune system.
Factors such as age, gender, family history, and exposure to certain chemicals or viruses may also play a role in the development of this type of lymphoma.
Prevalence and Risk
Diffuse large B-cell lymphoma is one of the most common types of non-Hodgkin lymphoma, accounting for about 30% of all cases.
It can affect people of all ages, but the risk increases with age, with the median age of diagnosis being around 65 years old.
Diagnosis
Diagnosing diffuse large B-cell lymphoma typically involves a combination of physical exams, imaging tests, blood tests, and a biopsy of the affected lymph node or tissue.
A pathologist will examine the biopsy sample to determine the presence of abnormal B-cells characteristic of this type of lymphoma.
Treatment and Recovery
Treatment for diffuse large B-cell lymphoma may include chemotherapy, radiation therapy, immunotherapy, and stem cell transplant, depending on the stage and severity of the disease.
The prognosis for patients with this type of lymphoma varies depending on various factors, but early detection and prompt treatment can greatly improve outcomes.
Prevention
Since the exact cause of diffuse large B-cell lymphoma is unknown, there are no specific prevention measures that can guarantee the avoidance of this disease.
However, maintaining a healthy lifestyle, avoiding exposure to harmful chemicals, and seeking prompt medical attention for any unusual symptoms can help reduce the risk of developing lymphoma.
Related Diseases
Diffuse large B-cell lymphoma is closely related to other types of non-Hodgkin lymphomas, such as follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma.
Each type of lymphoma has its unique characteristics and treatment options, but they all share the common feature of abnormal growth of lymphocytes.
Coding Guidance
When assigning the ICD-10 code C83.58 for diffuse large B-cell lymphoma, healthcare providers must ensure that the documentation supports the specific subtype of lymphoma to avoid coding errors.
Clear and accurate documentation of the patient’s medical history, physical exam findings, diagnostic tests, and treatment plan is essential for proper coding and billing.
Common Denial Reasons
Claims for diffuse large B-cell lymphoma may be denied due to insufficient documentation supporting the medical necessity of the services provided.
Other common denial reasons include coding errors, lack of prior authorization for certain treatments, and billing for non-covered services.